Cancer in the neonate is a rare event. Except for isolated case reports, there is little information on the prevalence, sites of origin, or tumour types encountered in this age group. Fraumeni and Miller, in a review of death certificates over a five year period in the United States, found the neonatal death rate from malignancies to be 1 per 6-24 million live births.' A study of mortality, however, does not represent the true prevalence as only certain malignancies are fatal. Bader and Miller reported that the prevalence of cancer in the first month of life in the United States was 36-5 per million live births,2 while Barson estimated the prevalence of congenital neoplasia to be 1/12 500 to 1/17 300 total births. 3 There are scant publications on the diagnosis and treatment of these patients, whose management poses unique problems.
We report the outcome of a group of 102 neonates found to have malignant diseases in a single institution over a 60 year period and their management problems.
Subjects and methods
The Hospital for Sick Children in Toronto, Canada, is the tertiary referral centre for most sick neonates and for paediatric malignancies seen in Ontario. During a 60 year period , 5290 cases of paediatric malignancy were seen at the hospital, 102 of whom were neonates under 29 days of age. The tumour registry, the medical records, and the pathology registry were examined to determine the prevalence of paediatric malignancies. The clinical records of the patients were reviewed. Histological sections of biopsy specimens or autopsy material, or both, and bone marrow aspirates were available in all patients, except three cases of neuroblastoma with increased urinary catecholamines and two cases of soft tissue sarcoma, and were reviewed by all the authors except ANC to confirm the diagnosis of the malignancy.
Results
One hundred and two neonates were diagnosed as having malignancy in the first 29 days of life. Forty two patients presented on the first day, 13 during the next six days, and the remaining 30 between days 7 and 29. Sixteen diagnoses of neuroblastoma and one of Wilms' tumour were made incidentally at autopsy in neonates who died of unrelated medical problems. There were 64 boys and 38 girls, giving a sex prevalence of 1-7:1. Table 1 shows the prevalence of different cancers and the mortality from disease. Forty two neonates (41%) died from their malignancy, 43 (42%) survived, and 17 died of unrelated medical problems.
Neuroblastoma was the most common neonatal 19 The clinical information on eight neonates with leukaemia is shown in Table 2 . Three patients had acute myelogenous leukaemia, one acute lymphoblastic leukaemia, and four acute undifferentiated leukaemia. All patients presented with anaemia, thrombocytopenia, high white blood cell counts, and organomegaly. One patient (case 8 in Table 2) also had meningeal leukaemia and leukaemic iritis, with leukaemic cells in the anterior chambers of his eyes at presentation. Four babies had leukaemic infiltration of the skin and two had testicular leukaemia at diagnosis. All eight died of their disease. The four who received no chemotherapy Twelve infants presented with soft tissue sarcomas in the neonatal period (Table 4) . Eight patients had rhabdomyosarcoma, three had undifferentiated sarcoma, and one had leiomyosarcoma. Ten of the 12 babies died of their disease. The two long term survivors included a patient with leiomyosarcoma of the colon and a patient with an undifferentiated sarcoma of the orbit. It is of interest that both were cured by surgery alone.
The miscellaneous group comprised three patients. The first patient had a malignant schwannoma of the humeral area. He was alive and free of disease at 3 years after excision only. The second patient presented at birth with a large presacral mass. This was completely removed, and histology showed a benign sacrococcygeal teratoma with a malignant focus of embryonal carcinoma. She had adjuvant chemotherapy and was alive and free of disease at 21 months. The third patient had a testicular endodermal sinus tumour, which was resected, and was alive and free of disease at 43 years.
Discussion
Tumour masses are fairly common findings in the neonatal period but are rarely malignant. In our series malignant neonatal tumours comprised only 2% of all childhood malignancies. The exact prevalence is difficult to determine, but in the United States it is reported to be in the region of 1 per 27 000 births. In an average size maternity hospital one such patient would be born every nine years. Any experience in this must be gathered over a period of years from a large neonatal referral centre.
Forty one per cent of the tumours were evident on the first day of life, but 17% were only found at autopsy as an incidental finding. Thus the true prevalence may well be higher than the figures quoted, bearing in mind that many neonatal deaths do not undergo postmortem examination. Unlike other series, we found a male predominance, with a sex prevalence of 1-7:1. This was similar to but even more pronounced than the male predominance of 1-2:1 in all paediatric cancers. 4 Prenatal factors may play a part and affect one sex more than the other.
Like others,5 we found no evidence of heredity in congenital malignancies, with the exception of four cases of familial retinoblastoma. Miller reported that certain childhood cancers were associated with congenital anomalies.6 One might expect that this association would be more pronounced in congenital neoplasia. We only found one case of leukaemia associated with Down's syndrome and ventricular septal defect, a well known association.7 Five patients with neuroblastoma had congenital heart disease, and one with neuroblastoma had multiple congenital abnormalities. There have been isolated reports describing the transplacental metastatic spread of cancer cells from mother to fetus in malignant melanoma,8 leukaemia,9 and choriocarcinoma.tt We found no such instances in our series. We previously reported one baby with congenital neuroblastoma who had clumps of tumour cells in the fetal but not the maternal vascular channels of the placenta." There was no evidence of transplacental spread of cancer from the child to the mother in this or in other reports. 12 Two mothers with recently diagnosed malignancies, colon and renal cell carcinoma, respectively, both gave birth to babies with congenital Wilms' tumour. We found no previous reports of similar associations and there was no evidence of maternal exposure to drugs or carcinogens that could have accounted for either the maternal or the neonatal tumours. Similarly, there was no history of maternal ingestion of alcohol or hydantoin anticonvulsants'3 14 2) We conclude that although neonatal malignancy is rare, a large percentage of the patients can be successfully treated and cured with little impairment to future well being. As the management of these patients poses great demands on both the parents and the physicians any proposed treatment and the risks should be thoroughly discussed with the parents before it is implemented. 
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